Literature DB >> 17627279

HP1alpha guides neuronal fate by timing E2F-targeted genes silencing during terminal differentiation.

Irina Panteleeva1, Stéphanie Boutillier, Violaine See, Dave G Spiller, Caroline Rouaux, Geneviève Almouzni, Delphine Bailly, Christèle Maison, Helen C Lai, Jean-Philippe Loeffler, Anne-Laurence Boutillier.   

Abstract

A critical step of neuronal terminal differentiation is the permanent withdrawal from the cell cycle that requires the silencing of genes that drive mitosis. Here, we describe that the alpha isoform of the heterochromatin protein 1 (HP1) protein family exerts such silencing on several E2F-targeted genes. Among the different isoforms, HP1alpha levels progressively increase throughout differentiation and take over HP1gamma binding on E2F sites in mature neurons. When overexpressed, only HP1alpha is able to ensure a timed repression of E2F genes. Specific inhibition of HP1alpha expression drives neuronal progenitors either towards death or cell cycle progression, yet preventing the expression of the neuronal marker microtubule-associated protein 2. Furthermore, we provide evidence that this mechanism occurs in cerebellar granule neurons in vivo, during the postnatal development of the cerebellum. Finally, our results suggest that E2F-targeted genes are packaged into higher-order chromatin structures in mature neurons relative to neuroblasts, likely reflecting a transition from a 'repressed' versus 'silenced' status of these genes. Together, these data present new epigenetic regulations orchestrated by HP1 isoforms, critical for permanent cell cycle exit during neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627279      PMCID: PMC1949014          DOI: 10.1038/sj.emboj.7601789

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

Review 1.  Genetic regulation of cerebellar development.

Authors:  V Y Wang; H Y Zoghbi
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

2.  Dynamic regulation of effector protein binding to histone modifications: the biology of HP1 switching.

Authors:  Holger L Dormann; Boo Shan Tseng; C David Allis; Hironori Funabiki; Wolfgang Fischle
Journal:  Cell Cycle       Date:  2006-12-15       Impact factor: 4.534

3.  Dynamic and selective interactions of the transcriptional corepressor TIF1 beta with the heterochromatin protein HP1 isotypes during cell differentiation.

Authors:  Florence Cammas; Agnes Janoshazi; Thierry Lerouge; Régine Losson
Journal:  Differentiation       Date:  2007-03-23       Impact factor: 3.880

4.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.

Authors:  A J Bannister; P Zegerman; J F Partridge; E A Miska; J O Thomas; R C Allshire; T Kouzarides
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

5.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.

Authors:  M Lachner; D O'Carroll; S Rea; K Mechtler; T Jenuwein
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

6.  Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family.

Authors:  A L Nielsen; J A Ortiz; J You; M Oulad-Abdelghani; R Khechumian; A Gansmuller; P Chambon; R Losson
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

7.  DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.

Authors:  K D Robertson; S Ait-Si-Ali; T Yokochi; P A Wade; P L Jones; A P Wolffe
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

8.  HP1 binding to chromatin methylated at H3K9 is enhanced by auxiliary factors.

Authors:  Ragnhild Eskeland; Anton Eberharter; Axel Imhof
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

9.  Phosphorylation site mutations in heterochromatin protein 1 (HP1) reduce or eliminate silencing activity.

Authors:  T Zhao; T Heyduk; J C Eissenberg
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

10.  Heterochromatin formation in mammalian cells: interaction between histones and HP1 proteins.

Authors:  A L Nielsen; M Oulad-Abdelghani; J A Ortiz; E Remboutsika; P Chambon; R Losson
Journal:  Mol Cell       Date:  2001-04       Impact factor: 17.970

View more
  32 in total

1.  Recurring mutations in myeloproliferative neoplasms alter epigenetic regulation of gene expression.

Authors:  Gary W Reuther
Journal:  Am J Cancer Res       Date:  2011-05-29       Impact factor: 6.166

Review 2.  Nuclear reprogramming and epigenetic rejuvenation.

Authors:  Prim B Singh; Fred Zacouto
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

3.  Gastrin-releasing peptide signaling alters colon cancer invasiveness via heterochromatin protein 1Hsβ.

Authors:  Robert Tell; Claudio A Rivera; Jillian Eskra; Lauren N Taglia; Adam Blunier; Q Tian Wang; Richard V Benya
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  Mechanisms controlling cell cycle exit upon terminal differentiation.

Authors:  Laura A Buttitta; Bruce A Edgar
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

Review 5.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

6.  A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence.

Authors:  Srikanth Talluri; Christian E Isaac; Mohammad Ahmad; Shauna A Henley; Sarah M Francis; Alison L Martens; Rod Bremner; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

Review 7.  Epigenetics in NG2 glia cells.

Authors:  Sarah Moyon; Jialiang Liang; Patrizia Casaccia
Journal:  Brain Res       Date:  2015-06-17       Impact factor: 3.252

Review 8.  WEE1 tyrosine kinase, a novel epigenetic modifier.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Trends Genet       Date:  2013-03-26       Impact factor: 11.639

9.  Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers.

Authors:  Masakatsu Takanashi; Kosuke Oikawa; Koji Fujita; Motoshige Kudo; Masao Kinoshita; Masahiko Kuroda
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

10.  Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma.

Authors:  Paul A Northcott; Yukiko Nakahara; Xiaochong Wu; Lars Feuk; David W Ellison; Sid Croul; Stephen Mack; Paul N Kongkham; John Peacock; Adrian Dubuc; Young-Shin Ra; Karen Zilberberg; Jessica McLeod; Stephen W Scherer; J Sunil Rao; Charles G Eberhart; Wiesia Grajkowska; Yancey Gillespie; Boleslaw Lach; Richard Grundy; Ian F Pollack; Ronald L Hamilton; Timothy Van Meter; Carlos G Carlotti; Frederick Boop; Darrell Bigner; Richard J Gilbertson; James T Rutka; Michael D Taylor
Journal:  Nat Genet       Date:  2009-03-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.